Please login to the form below

Meet two of OPEN Health’s practices - Peloton Advantage and Pharmerit at MAPS 2020

Turning scientific knowledge and data into evidence

March 3, 2020 - London, UK, Parsippany and Bethesda, USA – Meet two of OPEN Health’s practices—Peloton Advantage and Pharmerit International—at booth #4 at MAPS Global 2020, the World's Largest Assembly of Medical Affairs Professionals, to be held in Miami, Florida from March 8 – 11, 2020.

Peloton Advantage along with OPEN Health Medical Communications provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training. By joining OPEN Health in late 2019, Pharmerit deepens OPEN Health’s strategic and scientific capabilities in health economics and outcomes research (HEOR) and market access and expands Pharmerit’s ability to communicate with the broader scientific community. For more information on the two practices, please visit our website.

OPEN Health practices are supported by creative and digital teams to translate scientific concepts and communications into compelling visuals and deliver innovation with measurable results, all while ensuring data security and compliance. Together, the OPEN Health family is a full-service, trusted, innovative partner for Medical Affairs.

Contact:

OPEN Health: Sandy Royden
sandyroyden@openhealthgroup.com
+44 1628 481112

Peloton Advantage: Carolyn Clark
cclark@pelotonadvantage.com
+1 973 582 5701

Pharmerit International: Candice Subero

csubero@pharmerit.com

+1 240 483 4323

About OPEN Health Communications, LLP:

OPEN Health is a global multidisciplinary health communications and market access group, operating within three core business areas: Medical Communications; Patient and Brand Communications; and HEOR / Access and Evidence.  OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases, and specialist medicines.

For further information on OPEN Health, please visit www.openhealthgroup.com.

About Pharmerit International, LP:

Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in health economics and outcomes research (HEOR) and market access worldwide. Pharmerit delivers quality research across four multidisciplinary Centers of Excellence: Modeling & Meta-Analysis, Patient-Centred Outcomes, Real-World Evidence, and Strategic Market Access.Pharmerit has offices in Berlin, Bethesda, Boston, Mumbai, Oxford, New York, Rotterdam, York, and Shanghai.

For further information on Pharmerit International, please visit www.pharmerit.com.

About Peloton Advantage, LLC:

Peloton Advantage, LLC is a privately-owned medical communications company specializing in strategic publication planning and associated content development for medical education programs. Peloton’s teams support US and global accounts for large and small pharmaceutical, biotechnology, and medical device companies, contributing to the success of more than 90 products spanning all major therapeutic areas.

For further information on Peloton Advantage, please visit www.pelotonadvantage.com.

3rd March 2020

Share

Company Details

OPEN Health

+44 1628 481112

Contact Website

Address:
The Weighbridge
Brewery Courtyard
High Street
Marlow
Buckinghamshire
SL7 2FF
United Kingdom

Latest content on this profile

Drive, Discover, Dive_OPEN Health
Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.
OPEN Health
Novel Oncology Therapies Require Innovative Methods in Oncology Modeling
Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.
OPEN Health
The CM Group rebrands to OPEN Health
Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding and will now be known as OPEN Health.
OPEN Health
OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health to acquire leading US-based life science strategy and advisory firm Acsel Health
OPEN Health
OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member
OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.
OPEN Health
Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access
OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.
OPEN Health